ROUTINE QUALITY ASSURANCE REQUIREMENTS FOR APHERESED PLATELETS

被引:2
作者
HOGMAN, CF
机构
[1] Department of Clinical Immunology and Transfusion Medicine, University Hospital, Uppsala
来源
TRANSFUSION SCIENCE | 1993年 / 14卷 / 01期
关键词
D O I
10.1016/0955-3886(93)90061-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:85 / 88
页数:4
相关论文
共 8 条
[1]  
Council of Europe, Guide to the Preparation, Use and Quality Control of Cellular Blood Components, (1992)
[2]  
Department of Health in the UK, Guidelines for the Blood Transfusion Services in the United Kingdom 1989, (1989)
[3]  
McShine, Das, Smit Sibinga, Brozovic, Effect of EDTA on platelet count and other platelet parameters in blood and blood components collected with CPDA-1, Vox Sang, 61, pp. 84-89, (1991)
[4]  
Leikola, Myllyla, The clinical use of red blood cell components, Transfusion Therapy: Guidelines for Practice, pp. 1-25, (1990)
[5]  
Kratzer, Born, Simulation of primary haemostasis in vitro, Haemostasis, 15, pp. 357-362, (1985)
[6]  
Hogman, Gong, Eriksson, Hambraeus, Johansson, White cells protect donor blood against bacterial contamination, Transfusion, 31, pp. 620-626, (1991)
[7]  
Hogman, Gong, Hambraeus, Johansson, Eriksson, The role of leukocytes in the transmission of Yersinia enterocolitica with blood components, Transfusion, 32, pp. 654-657, (1992)
[8]  
Slichter, Mechanism and management of platelet refractoriness, Transfusion Medicine in the 1990's, pp. 95-179, (1990)